Universal anti-neuraminidase antibody inhibiting all influenza A subtypes

Antiviral Research

Volumn 100, Issue 2, 2013, Pages 567-574

  Doyle, Tracey M ^a,e   Hashem, Anwar M ^a,c   Li, Changgui ^d   Van Domselaar, Gary ^b   Larocque, Louise ^a   Wang, Junzhi ^d   Smith, Daryl ^a   Cyr, Terry ^a   Farnsworth, Aaron ^a   He, Runtao ^b   Hurt, Aeron C ^f   Brown, Earl G ^e   Li, Xuguang ^a,e  

^a Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^e UNIVERSITY OF OTTAWA   (Canada)

^f WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

Cross protection; Neuraminidase; Universal antibody

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HCA 2; UNCLASSIFIED DRUG; EPITOPE; NA PROTEIN, INFLUENZA A VIRUS; SIALIDASE; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS PROTECTION; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; INFLUENZA A; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H7N7; LETHAL DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; CROSS-PROTECTION; DISEASE MODEL; IMMUNOLOGY; ISOLATION AND PURIFICATION; ORTHOMYXOVIRUS INFECTION; UNIVERSAL ANTIBODY; VIROLOGY;

MUS; ORTHOMYXOVIRIDAE;

CROSS-PROTECTION; NEURAMINIDASE; UNIVERSAL ANTIBODY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CROSS PROTECTION; DISEASE MODELS, ANIMAL; EPITOPES, B-LYMPHOCYTE; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MICE; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; VIRAL PROTEINS;

EID: 84886079382     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.09.018     Document Type: Article

References (51)

1. G. Air Influenza neuraminidase Influenza Other Respir. Viruses 6 2011 245 256
2. G.M. Air, and W.G. Laver The neuraminidase of influenza virus Proteins 6 1989 341 356 10.1002/prot.340060402
3. A.T. Baker, J.N. Varghese, W.G. Laver, G.M. Air, and P.M. Colman Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus Proteins 2 1987 111 117 10.1002/prot.340020205
4. Z. Chen, S. Kadowaki, Y. Hagiwara, T. Yoshikawa, and K. Matsuo Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase Vaccine 18 2000 3214 3222
5. J. Chen, F. Fang, X. Li, H. Chang, and Z. Chen Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation Vaccine 23 2005 4322 4328
6. S. Chun, C. Li, G. Van Domselaar, J. Wang, A. Farnsworth, X. Cui, H. Rode, T.D. Cyr, R. He, and X. Li Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins Vaccine 26 2008 6068 6076 10.1016/j.vaccine.2008.09.015
7. P.M. Colman Structural basis of antigenic variation: studies of influenza virus neuraminidase Immunol. Cell Biol. 70 1992 209 214 10.1038/icb.1992.26
8. P.M. Colman, J.N. Varghese, and W.G. Laver Structure of the catalytic and antigenic sites in influenza virus neuraminidase Nature 303 1983 41 44
9. T.M. Doyle, B. Jaentschke, G. Van Domselaar, A.M. Hashem, A. Farnsworth, N.E. Forbes, C. Li, J. Wang, R. He, E.G. Brown, and X. Li The universal epitope of influenza A viral neuraminidase fundamentally contributes to enzyme activity and viral replication J. Biol. Chem. 288 25 2013 18283 18289 10.1074/jbc.M113.468884
10. D.C. Ekiert, G. Bhabha, M.A. Elsliger, R.H. Friesen, M. Jongeneelen, M. Throsby, J. Goudsmit, and I.A. Wilson Antibody recognition of a highly conserved influenza virus epitope Science 324 2009 246 251
11. D.C. Ekiert, R.H. Friesen, G. Bhabha, T. Kwaks, M. Jongeneelen, W. Yu, C. Ophorst, F. Cox, H.J. Korse, and B. Brandenburg A highly conserved neutralizing epitope on group 2 influenza A viruses Science 333 2011 843 850
12. S.L. Epstein, W.P. Kong, J.A. Misplon, C.Y. Lo, T.M. Tumpey, L. Xu, and G.J. Nabel Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein Vaccine 23 2005 5404 5410 10.1016/j.vaccine.2005. 04.047
13. E. Govorkova, and J. McCullers Therapeutics against influenza Curr. Top. Microbiol. Immunol. 370 2013 273 300
14. C. Gravel, C. Li, J. Wang, A.M. Hashem, B. Jaentschke, K.W. Xu, B. Lorbetskie, G. Gingras, Y. Aubin, G. Van Domselaar, M. Girard, R. He, and X. Li Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences Vaccine 28 2010 5774 5784 10.1016/j.vaccine.2010.06.075
15. C. Gravel, C. Li, J. Wang, A.M. Hashem, B. Jaentschke, G. Van Domselaar, R. He, and X. Li Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays J. Vis. Exp. 50 2011 10.3791/2784
16. J.A. Griffin, S. Basak, and R.W. Compans Effects of hexose starvation and the role of sialic acid in influenza virus release Virology 125 1983 324 334
17. A.M. Hashem, A.S. Flaman, A. Farnsworth, E.G. Brown, G. Van Domselaar, R. He, and X. Li Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases PLoS One 4 2009 e8350 10.1371/journal.pone.0008350
18. A.M. Hashem, T.M. Doyle, G. Van Domselaar, A. Farnsworth, C. Li, J. Wang, R. He, and X. Li Recent developments in bioinformatics analyses of influenza A virus surface glycoproteins and their biological relevance Curr. Bioinformatics 6 2011 415 426
19. E. Hoffmann, G. Neumann, Y. Kawaoka, G. Hobom, and R.G. Webster A DNA transfection system for generation of influenza A virus from eight plasmids Proc. Natl. Acad. Sci. U.S.A. 97 2000 6108 6113 10.1073/pnas.100133697
20. N.A. Ilyushina, N.V. Bovin, and R.G. Webster Decreased neuraminidase activity is important for the adaptation of H5N1 influenza virus to human airway epithelium J. Virol. 86 2012 4724 4733 10.1128/JVI.06774-11
21. B.E. Johansson, and I.C. Brett Changing perspective on immunization against influenza Vaccine 25 2007 3062 3065 10.1016/j.vaccine.2007.01.030
22. B.E. Johansson, and M.M. Cox Influenza viral neuraminidase; the forgotten antigen Expert Rev. Vaccines 10 12 2011 1683 1695
23. B.E. Johansson, D.J. Bucher, and E.D. Kilbourne Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection J. Virol. 63 1989 1239 1246
24. H. Kida, R.G. Webster, and R. Yanagawa Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on teh hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus Arch. Virol. 76 1983 91 99
25. J. Kim, R. Resende, T. Wennekes, H. Chen, N. Bance, S. Buchini, A. Watts, P. Pilling, V. Streltsov, M. Petric, R. Liggins, S. Barrett, L. McKimm-Breschkin, M. Niikura, and S. Withers Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity Science 340 6128 2013 71 75
26. C.R. Lambre, H. Terzidis, A. Greffard, and R.G. Webster An enzyme-linked lectin assay for sialidase Clin. Chim. Acta 198 1991 183 193
27. C. Liu, M.C. Eichelberger, R.W. Compans, and G.M. Air Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding J. Virol. 69 1995 1099 1106
28. G. Marcelin, R. DuBois, A. Rubrum, C. Russell, J. McElhaney, and R. Webby A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus PloS one 6 10 2011 e26335
29. G. Marcelin, M.R. Sandbulte, and R.J. Webby Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines Rev. Med. Virol. 22 2012 267 279
30. M.N. Matrosovich, T.Y. Matrosovich, T. Gray, N.A. Roberts, and H.D. Klenk Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium J. Virol. 78 2004 12665 12667 10.1128/JVI.78.22.12665- 12667.2004
31. J. McKimm-Breschkin Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance Influenza Other Respir. Viruses 1 2013 25 36
32. P. Palese, K. Tobita, M. Ueda, and R.W. Compans Characterization of temperature sensitive influenza virus mutants defective in neuraminidase Virology 61 1974 397 410
33. J. Ping, L. Keleta, N. Forbes, S. Dankar, W. Stecho, S. Tyler, Y. Zhou, L. Babiuk, H. Weingartl, R. Halpin, A. Boyne, J. Bera, J. Hostetler, N. Fedorova, K. Proudfoot, D. Katzel, T. Stockwell, E. Ghedin, D. Spiro, and E. Brown Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse PLoS one 6 6 2011 e21740
34. M. Qiu, F. Fang, Y. Chen, H. Wang, and Q. Chen Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice Biochem. Biophys. Res. Commun. 343 4 2006 1124 1131
35. G.F. Rimmelzwaan, R.A. Fouchier, and A.D. Osterhaus Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development Curr. Opin. Biotechnol. 18 2007 529 536
36. M.R. Sandbulte, G.S. Jimenez, A.C. Boon, L.R. Smith, and J.J. Treanor Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans PLoS Med. 4 2 2007 e59
37. P. Seiler, B.M. Senn, P. Klenerman, U. Kalinke, H. Hengartner, and R.M. Zinkernagel Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence J. Virol. 74 13 2000 5896 5901
38. J.J. Skehel, and D.C. Wiley Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin Annu. Rev. Biochem. 69 2000 531 569 10.1146/annurev.biochem.69.1.531
39. C. Smeenk, K. Wright, B. Burns, A. Thaker, and E. Brown Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis Virus Res. 44 2 1996 79 95
40. B. Su, S. Wurtzer, M.A. Rameix-Welti, D. Dwyer, S. van der Werf, N. Naffakh, F. Clavel, and B. Labrosse Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA) PLoS One 4 2009 e8495 10.1371/journal.pone.0008495
41. A. Takada, A. Matsushita, Y. Ninomiya, H. Kawoaka, and K. Kida Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice Vaccine 21 2003 3212 3218
42. C.A. Thomson, Y. Wang, L.M. Jackson, M. Olson, W. Wang, A. Liavonchanka, L. Keleta, V. Silva, S. Diederich, R.B. Jones, J. Gubbay, J. Pasick, M. Petric, F. Jean, V.G. Allen, E.G. Brown, J.M. Rini, and J.W. Schrader Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem Front. Immunol. 3 2012 87 10.3389/fimmu.2012.00087
43. M. Thosby, E. van den Brink, M. Jongeneelen, L.L. Poon, P. Alard, L. Cornelissen, A. Bakker, F. Cox, E. van Denventer, and Y. Guan Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells PloS one 3 12 2008 e3942
44. S. Tong, Y. Li, P. Rivailler, C. Conrardy, and D.A.A. Castillo A distinct lineage of influenza A virus from bats Proc. Natl. Acad. Sci. U.S.A. 109 2012 4269 4274
45. J.N. Varghese, W.G. Laver, and P.M. Colman Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution Nature 303 1983 35 40
46. R. Wagner, M. Matrosovich, and H.D. Klenk Functional balance between haemagglutinin and neuraminidase in influenza virus infections Rev. Med. Virol. 12 2002 159 166 10.1002/rmv.352
47. H. Wan, J. Gao, K. Xu, H. Chen, L.K. Couzens, K.H. Rivers, J.D. Easterbrook, K. Yang, L. Zhong, M. Rajabi, J. Ye, I. Sultana, X.F. Wan, X. Liu, D.R. Perez, J.K. Taubenberger, and M.C. Eichelberger Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses J. Virol. 87 16 2013 9290 9300
48. R.G. Webster, and W.J. Bean Jr Genetics of influenza virus Annu. Rev. Genet. 12 1978 415 431 10.1146/annurev.ge.12.120178.002215
49. R. Weltzin, and T.P. Monath Intranasal antibody prophylaxis for protection against viral disease Clin. Microbiol. Rev. 12 3 1999 383 393
50. S. Yoden, H. Kida, M. Kuwabara, R. Yanagawa, and R.G. Webster Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhbition by antibody Virus Res. 4 1986 251 261
51. R. Yoshida, H. Igarashi, N. Ozaki, D. Kishida, H. Tomabechi, K. Kida, A. Ito, and A. Takada Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses PLoS Pathog. 5 3 2009 e1000350